m m m mm
ductoryClinical Pharmacol mm
ogy 11th edition- m m
comprehensive-2022-2023
m
1. A mnursingminstructormismpreparingmamteachingmplanmformamgroupmof mnursingmstudentsmabo
ut mpharmacology.mWhenmdescribingmthismtopic,mtheminstructormwould mfocusmthemdiscussio
nmonmwhichmof mthemfollowingmasmanmessentialmaspect?
A) Drugmname
B) Drugmclass
C) Drugmaction
D) Drugmsourc
emAns:m CmFeedba
ck:
Pharmacologymismthemstudymof mdrugsmand mtheirmactionmonmlivingmorganisms.mThus,m anmes
sentialmaspect mof mpharmacologymismdrugmaction.mAnmunderstandingmof mthemdrugmname,mdr
ugmclass,mand mdrugmsourcemismimportant,mbut mthemmost mcriticalmaspect mrelated mtompharmac
ologymismhow mthemdrugmactsminmthembody.
2. A mnursingmstudent mismpreparingmtomadministermamprescribed mdrugmtomampatient.mThemstude
nt mreviewsminformationmabout mthemdrugmand mitsmactions.mWhichmof mthemfollowingmwould mb
emthembest mchoicemformobtainingmthisminformation?mSelect mallmthat mapply.
A) Nursingminstructor
B) Nursemassigned mtomthempatient
C) Clinicalmdrugmreference
D) Prescribingmhealthmcaremprovider
E) Clinicalmpharmacist
mAns:mC,mE
Feedback:
Althoughmthemnursingmstudent mcanmaskmthemnursingminstructor,mthemnursemassigned mtomthe
mpatient,mand mthemprescribingmhealthmcaremprovidermforminformationmabout mthemdrug,mthemb
est mchoicesmformdrugminformationmwould mincludemanmappropriatemdrugmreferencemand mthem
clinicalmpharmacist.
3. Whenmdescribingmthemvariousmtypesmof mmedicationsmtomamgroupmof mnursingmstudents
,mamnursingminstructormwould midentifymwhichmof mthemfollowingmasmamsourcemformderi
vingmmedications?mSelect mallmthat mapply.
A) Plants
B) Syntheticmsources
C) Mold
D) Minerals
E) Animals
Pagem 1
,Ans:mA,mB,mC,mD,mE
Feedback:
Medicationsmaremderived mfrommnaturalmsources,mformexample,mplants,mmolds,mminerals,man
d manimals,masmwellmasmcreated msyntheticallyminmamlaboratory.
Pagem 2
,TestBank for Roach’s Introductory
m m m m
Clinical Pharmacology 11th edition
m m m m
100 correct answered m m
4. Whichmof mthemfollowingmnamesmmaymbemassigned mtomamdrugmduringmthemprocessm
of mdevelopment?mSelect mallmthat mapply.
A) Chemicalmname
B) Officialmname
C) Pharmacologicmname
D) Trademname
E) Nonproprietarymname
mAns:m A,mB,mD,mE
Feedback:
Throughout mthemprocessmof mdevelopment,mdrugsmmaymhavemseveralmnamesmassigned mtomt
hemmincludingmamchemicalmname,mamgenericm(nonproprietary) mname,manmofficialmname,man
d mamtrademormbrand mname.
5. A mdrugmmaymbemclassified mbymwhichmof mthemfollowing?mSelect mallmthat mapply.
A) Themchemicalmtypemof mthemdrug'smactivemingredient
B) Themwaymthemdrugmismused mtomtreat mamspecificmcondition
C) Themgenericmnamemof mthemdrug
D) Themtrademnamemof mthemdrug
E) Themnonproprietarymnamemof mthemdru
gmAns:mA,mB
Feedback:
A mdrugmmaymbemclassified mbymthemchemicalmtypemof mthemactivemingredient mormbymthemwaymi
t mismused mtomtreat mamparticularmcondition.mGeneric,mtrade,mand mnonproprietarymrefermtomho
w mamdrugmismnamed.
6. A mgroupmof mnursingmstudentsmaremreviewingminformationmabout mthemprocessmof mdrugmd
evelopment minmthemUnited mStates.mThemstudentsmdemonstratemunderstandingmof mthismp
rocessmwhenmtheymidentifymthat mwhichmof mthemfollowingmcategoriesmaremassigned mbymth
emFood mand mDrugmAdministrationmtomnewlymapproved mdrugs?mSelect mallmthat mapply.
A) Metabolite
B) Noncontrolled msubstance
C) Prescription
D) Nonprescription
E) Controlled msubstance
mAns:mC,mD,mE
Feedback:
Oncemdrugsmaremapproved mformuse,mthemFDA massignsmthemdrugmtomonemof mthemfollowingm
categories:mprescription,mnonprescription,mormcontrolled msubstance.mMetabolitemrefersmto
mtheminactivemformmof mthemdrug.mNoncontrolled msubstancemismamtermmthat mismnot mused.
Pagem 3
, TestBank for Roach’s Introductory
m m m m
Clinical Pharmacology 11th edition
m m m m
100 correct answered m m
7. Whichmof mthemfollowingmwould mbemmost mimportant mformthemnursemtomdomtomensuremthems
afemusemof mprescriptionmdrugsminmtheminstitutionalmsetting?mSelect mallmthat mapply.
A) Administeringmdrugs
B) Monitoringmclientsmformdrugmeffects
C) Prescribingmdrugs
D) Evaluatingmclientsmformtoxicmeffects
E) Educatingmclients/caregiversmabout mdrug
smAns:mA,mB,mD,mE
Feedback:
Inmtheminstitutionalmsetting,mthemnurse'smrolemtomensuremsafemusemof mprescriptionmdrugsminc
ludesmadministeringmdrugs,mmonitoringmdrugmeffects,mevaluatingmformtoxicmeffects,mand med
ucatingmclientsmand mcaregiversmabout mdrugs.
8. Themnursemismhelpingmamclient mreview mamprescriptionmfrommthemhealthmcaremprovider.mWh
enmexaminingmthemprescription,mwhichmof mthemfollowingmwould mthemnursemexpect mtomfin
d mdocumented?mSelect mallmthat mapply.
A) Namemof mthemdrug
B) Dosagemof mthemdrug
C) Routemof mdrugmadministration
D) Timesmof mdrugmadministration
E) Licensed mprescriber'smsignatur
emAns:mA,mB,mC,mD,mE
Feedback:
Themprescriptionmmust mcontainmthemclient'smname,mthemnamemof mthemdrug,mthemdosage,mthe
mmethod mand mtimesmof madministration,mand mthemsignaturemof mthemlicensed mhealthmcarempro
vidermprescribingmthemdrug.
9. Aftermteachingmamgroupmof mnursingmstudentsmabout mnonprescriptionmdrugs,mthemnursingmi
nstructormdeterminesmthat mthemteachingmwasmsuccessfulmwhenmthemstudentsmidentifymwhic
hmof mthemfollowing?mSelect mallmthat mapply.
A) Theymrequiremamlicensed mhealthmcaremprovider'smsignature.
B) Theymaremreferred mtomasmover-the-countermdrugs.
C) Theymcanmbemtakenmwithout mriskmtomthemclient.
D) Theymhavemcertainmlabelingmrequirements.
E) Theymshould mbemtakenmonlymasmdirected monmthemlabe
l.mAns:mB,mD,mE
Feedback:
Nonprescriptionmdrugsmaremoftenmreferred mtomasmover-the-
counterm(OTC)mdrugs.mTheymdomnot mrequiremamprescriptionm(amlicensed mhealthmcare mprovi
der'smsignature)mbut mdomnot mcomemwithout mriskmtomthemclient.mThemfederalmgovernment mha
smimposed mlabelingmrequirementsmof mOTCmdrugsmand mtheymshould monlymbemtakenmasmdire
cted monmthemlabelmunlessmundermthemsupervisionmof mamhealthmcaremprovider.
Pagem 4